SEC Form 4 research
| Issuer | Bicara Therapeutics Inc. |
|---|---|
| Tickers | BCAX |
| Reporting owners | 36 |
| Officers and directors | 7 |
| Last public filing | 2026-09-10 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-10 | 2026-09-08 | Cohlhepp Ryan | S | 3,442 | $23.43 | Not reported |
| 2026-09-10 | 2026-09-08 | Cohlhepp Ryan | S | 14,058 | $22.77 | Not reported |
| 2026-08-14 | 2026-08-12 | Larson Jennifer | A | 285,000 | $0 | Not reported |
| 2026-08-12 | 2026-08-10 | Hyep Ivan | S | 12,500 | $27.97 | Not reported |
| 2026-08-12 | 2026-08-10 | Mazumdar Claire | S | 10,000 | $27.98 | Not reported |
| 2026-08-12 | 2026-08-10 | Cohlhepp Ryan | S | 18,750 | $27.98 | Not reported |
| 2026-07-29 | 2026-07-28 | Bender Jeremy | A | 38,950 | $0 | Not reported |
| 2026-07-29 | 2026-07-28 | Oliger Christy J. | A | 38,950 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.